世界のペグ化タンパク質市場

【英語タイトル】Global PEGylated Proteins Sales Market Report 2017

QYResearchが出版した調査資料(QYR757798)・商品コード:QYR757798
・発行会社(調査会社):QYResearch
・発行日:2017年3月31日
・ページ数:124
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
EnterpriseUSD8,000 ⇒換算¥872,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界のペグ化タンパク質市場について調査・分析し、ペグ化タンパク質の世界市場概観、ペグ化タンパク質の種類別市場分析、用途別市場分析、ペグ化タンパク質の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・ペグ化タンパク質の世界市場概観
・ペグ化タンパク質の種類別市場規模
・ペグ化タンパク質の用途別市場規模
・ペグ化タンパク質の世界市場規模
・ペグ化タンパク質の世界市場規模予測
・ペグ化タンパク質の主要地域別市場規模
・ペグ化タンパク質の北米市場規模・予測
・ペグ化タンパク質のヨーロッパ市場規模・予測
・ペグ化タンパク質の中国市場規模・予測
・ペグ化タンパク質の日本市場規模・予測
・ペグ化タンパク質のアジア市場規模・予測
・ペグ化タンパク質の製造メーカー分析
・ペグ化タンパク質のメーカー別生産量
・ペグ化タンパク質のメーカー別市場シェア
・ペグ化タンパク質の価格動向・価格分析
・ペグ化タンパク質の販売(売上高)動向
・ペグ化タンパク質の貿易(輸出・輸入)動向
・ペグ化タンパク質の産業チェーン分析
・ペグ化タンパク質のマーケティング戦略分析
・ペグ化タンパク質の販売業者(代理店)リスト
・ペグ化タンパク質の市場環境分析
...
【レポートの概要】

This report studies sales (consumption) of PEGylated Proteins in Global market, especially in United States, China, Europe, Japan, and Asia (Ex. China & Japan), focuses on top players in these regions/countries, with sales, price (USD/mg), revenue (M USD) and market share (%) for each player in these regions, coveringENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of PEGylated Proteins in these regions, from 2012 to 2023 (forecast), like
United States
China
Europe
Japan
Asia (Ex. China & Japan)

Split by product Types, with Sales, Revenue, Price and Gross Margin, market share and growth rate of each type, can be divided into
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor Viii
Monoclonal Antibodies
Others

Split by applications, this report focuses on sales, market share and growth rate of PEGylated Proteins in each application, can be divided into
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn’s Disease
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

1 PEGylated Proteins Overview 1
1.1 Product Overview and Scope of PEGylated Proteins 1
1.2 Classification of PEGylated Proteins 2
1.2.1 Colony Stimulating Factors 3
1.2.2 Interferons 4
1.2.3 Erythropoietin (EPO) 5
1.2.4 Recombinant Factor Viii 6
1.2.5 Monoclonal Antibodies 7
1.3 Applications of PEGylated Proteins 8
1.3.1 Cancer Treatment 9
1.3.2 Hepatitis 9
1.3.3 Chronic Kidney Disease 10
1.3.4 Leukaemia 10
1.3.5 SCID 10
1.3.6 Rheumatoid Arthritis & Crohn’s Disease 10
1.4 PEGylated Proteins Market by Regions 11
1.4.1 United States Status and Prospect (2012-2023) 11
1.4.2 China Status and Prospect (2012-2023) 12
1.4.3 Europe Status and Prospect (2012-2023) 13
1.4.4 Japan Status and Prospect (2012-2023) 14
1.4.5 Asia (Ex. China & Japan) Status and Prospect (2012-2023) 15
1.5 Global Market Size (Value and Volume) of PEGylated Proteins (2012-2023) 16
1.5.1 Global PEGylated Proteins Sales and Growth Rate (2012-2023) 16
1.5.2 Global PEGylated Proteins Revenue and Growth Rate (2012-2023) 17
2 Global PEGylated Proteins Competition by Manufacturers, Type and Application 18
2.1 Global PEGylated Proteins Market Competition by Manufacturers 18
2.1.1 Global PEGylated Proteins Sales and Market Share of Key Manufacturers (2012-2017) 18
2.1.2 Global PEGylated Proteins Revenue and Share by Manufacturers (2012-2017) 20
2.2 Global PEGylated Proteins (Volume and Value) by Type 22
2.2.1 Global PEGylated Proteins Sales and Market Share by Type (2012-2017) 22
2.2.2 Global PEGylated Proteins Revenue and Market Share by Type (2012-2017) 24
2.3 Global PEGylated Proteins (Volume and Value) by Regions 26
2.3.1 Global PEGylated Proteins Sales and Market Share by Regions (2012-2017) 26
2.3.2 Global PEGylated Proteins Revenue and Market Share by Regions (2012-2017) 28
2.4 Global PEGylated Proteins (Volume) by Application 30
3 United States PEGylated Proteins (Volume, Value and Sales Price) 32
3.1 United States PEGylated Proteins Sales and Value (2012-2017) 32
3.1.1 United States PEGylated Proteins Sales and Growth Rate (2012-2017) 32
3.1.2 United States PEGylated Proteins Revenue and Growth Rate (2012-2017) 33
3.1.3 United States PEGylated Proteins Sales Price Trend (2012-2017) 34
3.2 United States PEGylated Proteins Sales and Market Share by Manufacturers 34
3.3 United States PEGylated Proteins Sales and Market Share by Type 35
3.4 United States PEGylated Proteins Sales and Market Share by Applications 36
4 China PEGylated Proteins (Volume, Value and Sales Price) 37
4.1 China PEGylated Proteins Sales and Value (2012-2017) 37
4.1.1 China PEGylated Proteins Sales and Growth Rate (2012-2017) 37
4.1.2 China PEGylated Proteins Revenue and Growth Rate (2012-2017) 38
4.1.3 China PEGylated Proteins Sales Price Trend (2012-2017) 39
4.2 China PEGylated Proteins Sales and Market Share by Manufacturers 39
4.3 China PEGylated Proteins Sales and Market Share by Type 40
4.4 China PEGylated Proteins Sales and Market Share by Applications 41
5 Europe PEGylated Proteins (Volume, Value and Sales Price) 42
5.1 Europe PEGylated Proteins Sales and Value (2012-2017) 42
5.1.1 Europe PEGylated Proteins Sales and Growth Rate (2012-2017) 42
5.1.2 Europe PEGylated Proteins Revenue and Growth Rate (2012-2017) 43
5.1.3 Europe PEGylated Proteins Sales Price Trend (2012-2017) 44
5.2 Europe PEGylated Proteins Sales and Market Share by Manufacturers 44
5.3 Europe PEGylated Proteins Sales and Market Share by Type 45
5.4 Europe PEGylated Proteins Sales and Market Share by Applications 46
6 Japan PEGylated Proteins (Volume, Value and Sales Price) 47
6.1 Japan PEGylated Proteins Sales and Value (2012-2017) 47
6.1.1 Japan PEGylated Proteins Sales and Growth Rate (2012-2017) 47
6.1.2 Japan PEGylated Proteins Revenue and Growth Rate (2012-2017) 48
6.1.3 Japan PEGylated Proteins Sales Price Trend (2012-2017) 49
6.2 Japan PEGylated Proteins Sales and Market Share by Manufacturers 49
6.3 Japan PEGylated Proteins Sales and Market Share by Type 50
6.4 Japan PEGylated Proteins Sales and Market Share by Applications 51
7 Asia (Ex. China & Japan) PEGylated Proteins (Volume, Value and Sales Price) 52
7.1 Asia (Ex. China & Japan) PEGylated Proteins Sales and Value (2012-2017) 52
7.1.1 Asia (Ex. China & Japan) PEGylated Proteins Sales and Growth Rate (2012-2017) 52
7.1.2 Asia (Ex. China & Japan) PEGylated Proteins Revenue and Growth Rate (2012-2017) 53
7.1.3 Asia (Ex. China & Japan) PEGylated Proteins Sales Price Trend (2012-2017) 54
7.2 Asia (Ex. China & Japan) PEGylated Proteins Sales and Market Share by Manufacturers 54
7.3 Asia (Ex. China & Japan) PEGylated Proteins Sales and Market Share by Type 55
7.4 Asia (Ex. China & Japan) PEGylated Proteins Sales and Market Share by Applications 56
8 Global PEGylated Proteins Manufacturers Analysis 58
8.1 ENZON Pharmaceuticals 58
8.1.1 Company Basic Information, Manufacturing Base and Competitors 58
8.1.2 PEGylated Proteins Product Types, Application and Specification 58
8.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 59
8.1.4 Main Business/Business Overview 61
8.2 Merck Sharp & Dohme 61
8.2.1 Company Basic Information, Manufacturing Base and Competitors 61
8.2.2 PEGylated Proteins Product Types, Application and Specification 62
8.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 63
8.2.4 Main Business/Business Overview 65
8.3 Roche 65
8.3.1 Company Basic Information, Manufacturing Base and Competitors 65
8.3.2 PEGylated Proteins Product Types, Application and Specification 67
8.3.3 Roche PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 67
8.3.4 Main Business/Business Overview 68
8.4 Pfizer 69
8.4.1 Company Basic Information, Manufacturing Base and Competitors 69
8.4.2 PEGylated Proteins Product Types, Application and Specification 70
8.4.3 Pfizer PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 70
8.4.4 Main Business/Business Overview 71
8.5 Amgen 72
8.5.1 Company Basic Information, Manufacturing Base and Competitors 72
8.5.2 PEGylated Proteins Product Types, Application and Specification 73
8.5.3 Amgen PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 74
8.5.4 Main Business/Business Overview 75
8.6 UCB 76
8.6.1 Company Basic Information, Manufacturing Base and Competitors 76
8.6.2 PEGylated Proteins Product Types, Application and Specification 77
8.6.3 UCB PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 77
8.6.4 Main Business/Business Overview 79
8.7 Crealta (Savient) 79
8.7.1 Company Basic Information, Manufacturing Base and Competitors 79
8.7.2 PEGylated Proteins Product Types, Application and Specification 80
8.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 81
8.7.4 Main Business/Business Overview 82
9 PEGylated Proteins Manufacturing Cost Analysis 83
9.1 PEGylated Proteins Key Raw Materials Analysis 83
9.1.1 Key Raw Materials 83
9.1.2 Price Trend of Key Raw Materials 83
9.1.3 Key Suppliers of Raw Materials 83
9.1.4 Market Concentration Rate of Raw Materials 84
9.2 Proportion of Manufacturing Cost Structure 84
9.2.1 Raw Materials 84
9.2.2 Labor Cost 85
9.2.3 Manufacturing Expenses 93
9.3 Manufacturing Process Analysis of PEGylated Proteins 95
10 Industrial Chain, Sourcing Strategy and Downstream Buyers 96
10.1 PEGylated Proteins Industrial Chain Analysis 96
10.2 Upstream Raw Materials Sourcing 96
10.3 Raw Materials Sources of PEGylated Proteins Major Manufacturers in 2016 97
10.4 Downstream Buyers 97
11 Marketing Strategy Analysis, Distributors/Traders 98
11.1 Marketing Channel 98
11.1.1 Direct Marketing 98
11.1.2 Indirect Marketing 99
11.1.3 Marketing Channel Development Trend 100
11.2 Market Positioning 101
11.2.1 Pricing Strategy 101
11.2.2 Brand Strategy 103
11.2.3 Target Client 104
11.3 Distributors/Traders List 104
12 Market Effect Factors Analysis 105
12.1 Technology Progress/Risk 105
12.1.1 Substitutes Threat 105
12.1.2 Technology Progress in Related Industry 105
12.2 Consumer Needs/Customer Preference Change 105
12.3 Economic/Political Environmental Change 105
13 Global PEGylated Proteins Market Forecast (2017-2023) 107
13.1 Global PEGylated Proteins Sales, Revenue Forecast (2017-2023) 107
13.2 Global PEGylated Proteins Sales Forecast by Regions (2017-2023) 108
13.3 Global PEGylated Proteins Sales Forecast by Type (2017-2023) 109
13.4 Global PEGylated Proteins Sales Forecast by Application (2017-2023) 109
14 Appendix 110
14.1 Methodology 110
14.2 Analyst Introduction 111
14.3 Data Source 112
14.4 Disclaimer 112

List of Tables and Figures

Figure Picture of PEGylated Proteins 2
Table Classification of PEGylated Proteins 2
Table FDA-approved PEGylated Drugs 3
Figure Global Sales Market Share of PEGylated Proteins by Types in 2016 3
Figure Colony Stimulating Factors Picture 4
Figure Interferons Picture 5
Figure Erythropoietin (EPO) Picture 6
Figure Recombinant Factor Viii Picture 7
Figure Monoclonal Antibodies Picture 8
Table Applications of PEGylated Proteins 8
Figure Global Sales Market Share of PEGylated Proteins by Applications in 2016 9
Figure United States PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 11
Figure China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 12
Figure Europe PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 13
Figure Japan PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 14
Figure Asia (Ex. China & Japan) PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 15
Figure Global PEGylated Proteins Sales (g) and Growth Rate (2012-2023) 16
Figure Global PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2023) 17
Table Global PEGylated Proteins Sales (g) of Key Manufacturers (2012-2017) 18
Table Global PEGylated Proteins Sales Share by Manufacturers (2012-2017) 18
Figure 2016 PEGylated Proteins Sales Share by Manufacturers 19
Figure 2017 PEGylated Proteins Sales Share by Manufacturers 19
Table Global PEGylated Proteins Revenue (Million USD) by Manufacturers (2012-2017) 20
Table Global PEGylated Proteins Revenue Share by Manufacturers (2012-2017) 20
Figure 2016 Global PEGylated Proteins Revenue Share by Manufacturers 21
Figure 2017 Global PEGylated Proteins Revenue Share by Manufacturers 21
Table Global PEGylated Proteins Sales (g) and Market Share by Type (2012-2017) 22
Table Global PEGylated Proteins Sales Share by Type (2012-2017) 22
Figure Sales Market Share of PEGylated Proteins by Type (2012-2017) 23
Figure Global PEGylated Proteins Sales Growth Rate by Type (2012-2017) 23
Table Global PEGylated Proteins Revenue (Million USD) by Type (2012-2017) 24
Table Global PEGylated Proteins Revenue Market Share by Type (2012-2017) 24
Figure Global Revenue Market Share of PEGylated Proteins by Type in 2016 25
Figure Global Revenue Market Share of PEGylated Proteins by Type in 2017 25
Table Global PEGylated Proteins Sales (g) and Market Share by Regions (2012-2017) 26
Table Global PEGylated Proteins Sales Share by Regions (2012-2017) 26
Figure Sales Market Share of PEGylated Proteins by Regions in 2016 27
Figure Sales Market Share of PEGylated Proteins by Regions in 2017 27
Table Global PEGylated Proteins Revenue (Million USD) by Regions (2012-2017) 28
Table Global PEGylated Proteins Revenue Share by Regions (2012-2017) 28
Figure Revenue Market Share of PEGylated Proteins by Regions in 2016 29
Figure Revenue Market Share of PEGylated Proteins by Regions in 2017 29
Table Global PEGylated Proteins Sales (g) by Application (2012-2017) 30
Table Global PEGylated Proteins Sales Share by Application (2012-2017) 30
Figure Sales Market Share of PEGylated Proteins by Application (2012-2017) 31
Figure Global PEGylated Proteins Sales Growth Rate by Application (2012-2017) 31
Figure United States PEGylated Proteins Sales (g) and Growth Rate (2012-2017) 32
Figure United States PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2017) 33
Figure United States PEGylated Proteins Sales Price (USD/mg) Trend (2012-2017) 34
Table United States PEGylated Proteins Sales (g) by Manufacturers (2012-2017) 34
Table United States PEGylated Proteins Market Share by Manufacturers (2012-2017) 35
Table United States PEGylated Proteins Sales (g) by Type (2012-2017) 35
Table United States PEGylated Proteins Market Share by Type (2012-2017) 35
Table United States PEGylated Proteins Sales (g) by Applications (2012-2017) 36
Table United States PEGylated Proteins Market Share by Applications (2012-2017) 36
Figure China PEGylated Proteins Sales (g) and Growth Rate (2012-2017) 37
Figure China PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2017) 38
Figure China PEGylated Proteins Sales Price (USD/mg) Trend (2012-2017) 39
Table China PEGylated Proteins Sales (g) by Manufacturers (2012-2017) 39
Table China PEGylated Proteins Market Share by Manufacturers (2012-2017) 40
Table China PEGylated Proteins Sales (g) by Type (2012-2017) 40
Table China PEGylated Proteins Market Share by Type (2012-2017) 40
Table China PEGylated Proteins Sales (g) by Applications (2012-2017) 41
Table China PEGylated Proteins Market Share by Applications (2012-2017) 41
Figure Europe PEGylated Proteins Sales (g) and Growth Rate (2012-2017) 42
Figure Europe PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2017) 43
Figure Europe PEGylated Proteins Sales Price (USD/mg) Trend (2012-2017) 44
Table Europe PEGylated Proteins Sales (g) by Manufacturers (2012-2017) 44
Table Europe PEGylated Proteins Market Share by Manufacturers (2012-2017) 45
Table Europe PEGylated Proteins Sales (g) by Type (2012-2017) 45
Table Europe PEGylated Proteins Market Share by Type (2012-2017) 45
Table Europe PEGylated Proteins Sales (g) by Applications (2012-2017) 46
Table Europe PEGylated Proteins Market Share by Applications (2012-2017) 46
Figure Japan PEGylated Proteins Sales (g) and Growth Rate (2012-2017) 47
Figure Japan PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2017) 48
Figure Japan PEGylated Proteins Sales Price (USD/mg) Trend (2012-2017) 49
Table Japan PEGylated Proteins Sales (g) by Manufacturers (2012-2017) 49
Table Japan PEGylated Proteins Market Share by Manufacturers (2012-2017) 50
Table Japan PEGylated Proteins Sales (g) by Type (2012-2017) 50
Table Japan PEGylated Proteins Market Share by Type (2012-2017) 50
Table Japan PEGylated Proteins Sales (g) by Applications (2012-2017) 51
Table Japan PEGylated Proteins Market Share by Applications (2012-2017) 51
Figure Asia (Ex. China & Japan) PEGylated Proteins Sales (g) and Growth Rate (2012-2017) 52
Figure Asia (Ex. China & Japan) PEGylated Proteins Revenue (Million USD) and Growth Rate (2012-2017) 53
Figure Asia (Ex. China & Japan) PEGylated Proteins Sales Price (USD/mg) Trend (2012-2017) 54
Table Asia (Ex. China & Japan) PEGylated Proteins Sales (g) by Manufacturers (2012-2017) 54
Table Asia (Ex. China & Japan) PEGylated Proteins Market Share by Manufacturers (2012-2017) 55
Table Asia (Ex. China & Japan) PEGylated Proteins Sales (g) by Type (2012-2017) 55
Table Asia (Ex. China & Japan) PEGylated Proteins Market Share by Type (2012-2017) 55
Table Asia (Ex. China & Japan) PEGylated Proteins Sales (g) by Applications (2012-2017) 56
Table Asia (Ex. China & Japan) PEGylated Proteins Market Share by Applications (2012-2017) 56
Table ENZON Pharmaceuticals Basic Information List 58
Figure ADAGEN Specification 59
Table ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 59
Figure ENZON Pharmaceuticals PEGylated Proteins Sales and Growth Rate (2012-2017) 60
Figure ENZON Pharmaceuticals PEGylated Proteins Global Market Share (2012-2017) 60
Table Merck Sharp & Dohme Basic Information List 61
Figure Merck Sharp & Dohme Peglntron Product Figure and Specification 62
Table Merck Sharp & Dohme PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 63
Figure Merck Sharp & Dohme PEGylated Proteins Sales and Growth Rate (2012-2017) 64
Figure Merck Sharp & Dohme PEGylated Proteins Global Market Share (2012-2017) 64
Table Roche Basic Information List 65
Figure Roche Mircera Product Picture 67
Table Roche PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 67
Figure Roche PEGylated Proteins Sales and Growth Rate (2012-2017) 68
Figure Roche PEGylated Proteins Global Market Share (2012-2017) 68
Table Pfizer Basic Information List 69
Figure Pfizer SOMAVERT Product Picture 70
Table Pfizer PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 70
Figure Pfizer PEGylated Proteins Sales and Growth Rate (2012-2017) 71
Figure Pfizer PEGylated Proteins Global Market Share (2012-2017) 71
Table Amgen Basic Information List 72
Figure Amgen Neulasta Product Picture and Specification 74
Table Amgen PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 74
Figure Amgen PEGylated Proteins Sales and Growth Rate (2012-2017) 75
Figure Amgen PEGylated Proteins Global Market Share (2012-2017) 75
Table UCB Basic Information List 76
Figure UCB CIMZIA Product Specification 77
Table UCB PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 77
Figure UCB PEGylated Proteins Sales and Growth Rate (2012-2017) 78
Figure UCB PEGylated Proteins Global Market Share (2012-2017) 78
Table Crealta (Savient) Basic Information List 79
Figure Crealta (Savient) KRYSTEXXA Product Picture 80
Table Crealta (Savient) PEGylated Proteins Sales, Revenue, Price and Gross Margin (2012-2017) 81
Figure Crealta (Savient) PEGylated Proteins Sales and Growth Rate (2012-2017) 81
Figure Crealta (Savient) PEGylated Proteins Global Market Share (2012-2017) 82
Table Production Base and Market Concentration Rate of Raw Material 83
Table Key Suppliers of Raw Materials 83
Figure Manufacturing Cost Structure of PEGylated Proteins 84
Figure USA Average Hourly Wages (USD/Hour) in Manufacturing 85
Figure USA Labor Cost Analysis 86
Figure Cost of Employing a Factory Worker 88
Figure Germany Average Hourly Wages in Manufacturing Index 89
Figure UK Average Weekly Wages (GBP/Week) in Manufacturing 89
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe 90
Figure China Average Yearly Wages (CNY/Year) in Manufacturing 91
Figure Monthly Minimum Wages in Asia 2016 91
Figure China Labor Costs 92
Figure Unit labor Costs in Canada in 2016, by Industry (in Canadian dollars per unit of real GDP) 93
Table 2015 Global Average Wage (USD/ Month) by Country 94
Figure Manufacturing Process Analysis of PEGylated Proteins 95
Figure PEGylated Proteins Industrial Chain Analysis 96
Table Raw Materials Sources of PEGylated Proteins Major Manufacturers in 2016 97
Table Distributors/Traders List 104
Figure Global PEGylated Proteins Sales (g) and Growth Rate Forecast (2017-2023) 107
Figure Global PEGylated Proteins Revenue (Million USD) and Growth Rate Forecast (2017-2023) 108
Table Global PEGylated Proteins Sales (g) Forecast by Regions (2017-2023) 108
Table Global PEGylated Proteins Sales (g) Forecast by Type (2017-2023) 109
Table Global PEGylated Proteins Sales (g) Forecast by Application (2017-2023) 109

★調査レポート[世界のペグ化タンパク質市場] (コード:QYR757798)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペグ化タンパク質市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆